Cargando…

NLRX1 negatively modulates type I IFN to facilitate KSHV reactivation from latency

Kaposi’s sarcoma-associated herpesvirus (KSHV) is a herpesvirus that is linked to Kaposi’s sarcoma (KS), primary effusion lymphoma (PEL) and multicentric Castleman’s disease (MCD). KSHV establishes persistent latent infection in the human host. KSHV undergoes periods of spontaneous reactivation wher...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Zhe, Hopcraft, Sharon E., Yang, Fan, Petrucelli, Alex, Guo, Haitao, Ting, Jenny P-Y, Dittmer, Dirk P., Damania, Blossom
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5426799/ https://www.ncbi.nlm.nih.gov/pubmed/28459883 http://dx.doi.org/10.1371/journal.ppat.1006350

Ejemplares similares

Regulation of KSHV Latency and Lytic Reactivation
por: Broussard, Grant, et al.
Publicado: (2020)

Mitochondrial protein, TBRG4, modulates KSHV and EBV reactivation from latency
por: Zhang, Huirong, et al.
Publicado: (2022)

Chromatin remodeling controls Kaposi's sarcoma-associated herpesvirus reactivation from latency
por: Hopcraft, Sharon E., et al.
Publicado: (2018)

ADAR1 Facilitates KSHV Lytic Reactivation by Modulating the RLR-Dependent Signaling Pathway
por: Zhang, Huirong, et al.
Publicado: (2020)

Barrier-to-autointegration factor 1 promotes gammaherpesvirus reactivation from latency
por: Broussard, Grant, et al.
Publicado: (2023)

KSHV: Immune Modulation and Immunotherapy
por: Broussard, Grant, et al.
Publicado: (2020)

KSHV Latency Locus Cooperates with Myc to Drive Lymphoma in Mice
por: Sin, Sang-Hoon, et al.
Publicado: (2015)

The Viral Interferon Regulatory Factors of KSHV: Immunosuppressors or Oncogenes?
por: Jacobs, Sarah R., et al.
Publicado: (2011)

AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV
por: Bhatt, Aadra P., et al.
Publicado: (2013)

KSHV LANA—The Master Regulator of KSHV Latency
por: Uppal, Timsy, et al.
Publicado: (2014)

Systemically Circulating Viral and Tumor-Derived MicroRNAs in KSHV-Associated Malignancies
por: Chugh, Pauline E., et al.
Publicado: (2013)

Air-Liquid Interface System To Understand Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma
por: Hopcraft, Sharon E., et al.
Publicado: (2018)

Hsp90 and Hsp40/Erdj3 are required for the expression and anti-apoptotic function of KSHV K1
por: Wen, Kwun Wah, et al.
Publicado: (2010)

The KSHV K1 Protein Modulates AMPK Function to Enhance Cell Survival
por: Anders, Penny M., et al.
Publicado: (2016)

Macrophages drive KSHV B cell latency
por: Szymula, Agnieszka, et al.
Publicado: (2023)

Electron microscopy mapping of the DNA-binding sites of monomeric, dimeric, and multimeric KSHV RTA protein
por: Calhoun, Jayla C., et al.
Publicado: (2023)

Latently KSHV-Infected Cells Promote Further Establishment of Latency upon Superinfection with KSHV
por: Gam ze Letova, Chen, et al.
Publicado: (2021)

KSHV Reactivation from Latency Requires Pim-1 and Pim-3 Kinases to Inactivate the Latency-Associated Nuclear Antigen LANA
por: Cheng, Fang, et al.
Publicado: (2009)

Treatment of Kaposi Sarcoma-Associated Herpesvirus-Associated Cancers
por: Dittmer, Dirk P., et al.
Publicado: (2012)

MLL1 is regulated by KSHV LANA and is important for virus latency
por: Tan, Min, et al.
Publicado: (2021)

NLRX1 Facilitates Histoplasma capsulatum-Induced LC3-Associated Phagocytosis for Cytokine Production in Macrophages
por: Huang, Juin-Hua, et al.
Publicado: (2018)

Toll-Like Receptor-3 Is Dispensable for the Innate MicroRNA Response to West Nile Virus (WNV)
por: Chugh, Pauline E., et al.
Publicado: (2014)

Phase separation and DAXX redistribution contribute to LANA nuclear body and KSHV genome dynamics during latency and reactivation
por: Vladimirova, Olga, et al.
Publicado: (2021)

Determinants of mTOR inhibitor therapy in AIDS-associated malignancies
por: Dittmer, Dirk P, et al.
Publicado: (2012)

Combined Inhibition of Akt and mTOR Is Effective Against Non-Hodgkin Lymphomas
por: Rivera-Soto, Ricardo, et al.
Publicado: (2021)

Nucleophosmin Phosphorylation by v-Cyclin-CDK6 Controls KSHV Latency
por: Sarek, Grzegorz, et al.
Publicado: (2010)

Targeting the PI3K/AKT/MTOR pathway in KSHV-associated cancers
por: Bhatt, A, et al.
Publicado: (2009)

NEDDylation Is Essential for Kaposi’s Sarcoma-Associated Herpesvirus Latency and Lytic Reactivation and Represents a Novel Anti-KSHV Target
por: Hughes, David J., et al.
Publicado: (2015)

Influence of ND10 Components on Epigenetic Determinants of Early KSHV Latency Establishment
por: Günther, Thomas, et al.
Publicado: (2014)

BET-Inhibitors Disrupt Rad21-Dependent Conformational Control of KSHV Latency
por: Chen, Horng-Shen, et al.
Publicado: (2017)

NLRX1 suppresses tumorigenesis and attenuates histiocytic sarcoma through the negative regulation of NF-λB signaling
por: Coutermarsh-Ott, Sheryl, et al.
Publicado: (2016)

Nlrx1 regulates neuronal cell death
por: Imbeault, Emilie, et al.
Publicado: (2014)

Induction of KSHV latency-associated nuclear antigen (LANA) by hypoxia and hypoxia-inducible factors (HIF)
por: Veeranna, Ravindra P, et al.
Publicado: (2012)

Targeting mTOR with MLN0128 Overcomes Rapamycin and Chemoresistant Primary Effusion Lymphoma
por: Caro-Vegas, Carolina, et al.
Publicado: (2019)

Molecular Biology of KSHV Lytic Reactivation
por: Purushothaman, Pravinkumar, et al.
Publicado: (2015)

Apoptotic caspases suppress an MDA5-driven IFN response during productive replication of human papillomavirus type 31
por: Huang, Ning, et al.
Publicado: (2022)

Sphingosine Kinase-2 Maintains Viral Latency and Survival for KSHV-Infected Endothelial Cells
por: Dai, Lu, et al.
Publicado: (2014)

A Unique SUMO-2-Interacting Motif within LANA Is Essential for KSHV Latency
por: Cai, Qiliang, et al.
Publicado: (2013)

Deregulation of KSHV latency conformation by ER-stress and caspase-dependent RAD21-cleavage
por: De Leo, Alessandra, et al.
Publicado: (2017)

Hsp90 Inhibitors Are Efficacious against Kaposi Sarcoma by Enhancing the Degradation of the Essential Viral Gene LANA, of the Viral Co-Receptor EphA2 as well as Other Client Proteins
por: Chen, Wuguo, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4a7qdsc57k54fbbe7t23n90d06